GI Cell said Monday that they signed a research and development collaboration agreement with HK inno.N to develop allogenic CAR-NK candidates and advance the development of numerous CAR-NK therapies.CAR-NK (Chimeric antigen receptor-natural killer) therapy is a novel immunotherapy strategy that util
SK Chemicals said it won a patent for Teglutik Oral Suspension, a treatment for Lou Gehrig’s disease, three months after winning marketing approval.The patent aims to make Teglutik the nation’s only oral suspension to treat Lou Gehrig’s.According to the Ministry of Food and Drug Safety, the regulato
Korea needs to establish a rapid diagnosis and treatment system before the Chuseok holiday (Sept. 9-12), as the number of high-risk group patients may exceed 20,000 a day afterward, a top quarantine advisor said.“The number of new Covid-19 cases tends to increase after holidays. Suppose daily infect
HK inno.N said that it recently shipped the first batch of K-CAB (ingredient: tegoprazan), a drug for gastroesophageal reflux disease (GERD), to Mongolia.The shipment made Mongolia the second country among the company’s 34 overseas markets where HK inno.N plans to launch K-CAB. China is the first fo
Humasis said its board of directors decided to establish a U.S. subsidiary on Friday and started preparations.In a public disclosure, Humasis said it would invest $2 million to complete the establishment of the U.S. offshoot by September.Humasis will purchase new shares of the U.S. subsidiary 100 pe
Ildong Pharmaceutical said it has completed a phase 2/3 trial of Xocova (pipeline name: S-217622), an oral Covid-19 treatment candidate, in Korea.In a public filing on Friday, the company said it ended the phase 2/3 trial of S-217622 in patients infected with SARS-CoV-2 and submitted the clinical st
Korea Biomedical Review, Korea’s first English-language medical and biopharmaceutical newspaper, has named Kim Yoon-mi its new managing editor.Kim graduated from Hankuk University of Foreign Studies with a bachelor's degree in English Interpretation and Translation and worked as the financial team l
The Seoul National University Hospital (SNUH) is speeding up efforts to open a cancer center in Busan for heavy ion therapy.On Wednesday, the SNUH said it signed an agreement with Swedish company RaySearch Laboratories to use the latter’s treatment planning system (TPS) and oncology information syst
Pfizer’s oral Covid-19 treatment Paxlovid helped Covid-19 patients aged 65 or older reduce hospitalization and death rates, but the effect was nonexistent among younger adult patients, a study showed.The Clalit Research Institute in Israel and Harvard Medical School in the U.S. published their study
Lululab said the Korean Intellectual Property Office (KIPO) has selected the company’s AI-based skin-specialized remote treatment technology as its “2022 IP-R&D strategic support project” in the biopharmaceutical sector.The KIPO’s IP project supports a customized and close patent strategy linking in
Although new virus cases are decreasing, the number of Covid-19 deaths recorded a three-digit figure for the first time in more than 100 days on Thursday, raising concerns among experts.According to the Korea Disease Control and Prevention Agency (KDCA), Korea confirmed 113,371 new infections, down
Middle-aged people who sleep less than six hours during weekdays can reduce their risks of depression by catching up on sleep at weekends, a recent study showed.A research team, led by Professor Oh Yoon-hwan of family medicine at Chung Ang University Gwangmyong Hospital, released the paper “Associat
Yuhan Corp.’s degenerative disc treatment Remedisc (pipeline name in Korea: YH14618), licensed to an American pharmaceutical firm, entered a phase 3 trial in the U.S.On Friday, Yuhan announced that the first patient received YH14618 in the phase 3 study in the U.S.Yuhan’s partner, Spine BioPharma, c
Lunit said it received a class 2 medical device license for Lunit INSIGHT MMG, the company's artificial intelligence (AI) solution for mammography analysis, from the Taiwan Food and Drug Administration (TFDA).According to Lunit, Lunit INSIGHT MMG is one of the company's most mature radiology product
The government’s move to redirect some of the budgets for allowances for Covid-19 treating healthcare workers to hold an international conference sparked a controversy in the medical community.Also, industry watchers said that the government’s six-month delay in paying allowances to healthcare worke
VaxCell Biotherapeutics said it would end its dendritic cell clinical trial of Vax-DC/MM and step up efforts to develop CAR-MIL as an alternative treatment for multiple myeloma.Existing treatments for multiple myeloma have shown limitations. For instance, there are a wide variety of antigens that ca
Ildong Pharmaceutical successfully registered a patent on Reyvow Tab. (ingredient: lasmiditan hemisuccinate), a migraine treatment, blocking a possible market entry by a latecomer drugmaker.On Aug. 5, the Ministry of Food and Drug Safety (MFDS) put Ildong’s Reyvow Tab. 100mg and Reyvow Tab. 50mg on
Vuno said on Wednesday that it launched a Patient Assistance Program (PAP) to provide its artificial intelligence (AI)-based cardiac arrest prediction medical device, VUNO Med-DeepCARS, to the recipients of medical benefits free of charge.Stressing that it seeks "patient-centered healthcare," Vuno s
A research team at Severance Hospital has found that patients with periodontal disease have a higher risk of suffering from cancer, stressing the need for proper dental care.Periodontal disease causes gum inflammation due to increased bacteria in the mouth that causes plaque to become toxic. If pati
The government said Wednesday it is collecting opinions on whether to abolish the mandatory Covid-19 test before entering Korea.Currently, quarantine authorities require all inbound travelers to submit a negative confirmation of a polymerase chain reaction (PCR) test within 48 hours before entry or